Description
Tadajuv ODF (Tadalafil) 20 mg
Tadajuv ODF is a tadalafil product. Tadalafil is a prescription phosphodiesterase type 5 (PDE5) inhibitor used for erectile dysfunction in adult men. The available regulatory and scientific sources support tadalafil as the active ingredient and PDE5 inhibition as its main pharmacological action. The “orally disintegrating film” presentation is a dosage form description; verified medical information should be based on tadalafil itself.
Active Ingredient and Medicine Class
Active ingredient: tadalafil.
Medicine class: phosphodiesterase type 5 (PDE5) inhibitor. PDE5 inhibitors increase cyclic guanosine monophosphate (cGMP) signalling in smooth muscle tissue, which helps relax penile blood vessels during sexual stimulation.
Established Medical Uses
Tadalafil is established for the treatment of erectile dysfunction in adult men. Regulatory product information also recognizes use in some regions for benign prostatic hyperplasia-related lower urinary tract symptoms and certain pulmonary arterial hypertension products, but those uses depend on the specific licensed product and formulation. For erectile dysfunction, sexual stimulation is required for the medicine to be effective.
How It Works
Tadalafil selectively inhibits PDE5, the enzyme that breaks down cGMP. By preserving cGMP, it supports smooth muscle relaxation and increased blood flow in erectile tissue after sexual stimulation. Reviews of the class also note tadalafil’s relatively long duration of action compared with some other PDE5 inhibitors.
Important Safety Information
Tadalafil must not be used with nitrates in any form because the combination can cause a dangerous drop in blood pressure. It is also contraindicated in people with a known serious hypersensitivity to tadalafil. Caution is required with alpha-blockers, antihypertensive medicines, and strong CYP3A4 inhibitors because of interaction risk. Regulatory information also warns against use when sexual activity is inadvisable because of cardiovascular disease.
Additional precautions in official product information include penile anatomical deformity or conditions that may predispose to priapism, and a history of certain recent cardiovascular or cerebrovascular events, depending on the product label.
Possible Side Effects
Commonly reported adverse effects include headache, dyspepsia, back pain, myalgia, flushing, nasal congestion, and dizziness. Less common but important serious reactions include priapism, sudden hearing loss, visual disturbances, severe hypersensitivity reactions, and cardiovascular events reported in post-marketing experience.
Scientific Evidence
Peer-reviewed reviews and clinical analyses support tadalafil as an effective treatment for erectile dysfunction across a range of severities and causes. Evidence summaries report improvement in erectile function outcomes and note that the medicine’s longer half-life supports a wider therapeutic window. Reviews also consistently identify headache and dyspepsia among the most frequent adverse effects.
Medical Information Notice
This summary is educational and based on sources available at the time of review. It does not replace the official patient leaflet, prescribing information, or assessment by a qualified healthcare professional.
Medical Sources
- DailyMed / FDA: Tadalafil Tablets, for oral use — Prescribing information
- FDA: CIALIS (tadalafil) tablets, for oral use — Prescribing information
- Meuleman EJH et al. “Review of tadalafil in the treatment of erectile dysfunction.” Expert Opinion on Pharmacotherapy (2003). PubMed
